dr. andreadis discusses fda-approved car t-cell therapies in dlbcl
Published 5 years ago • 157 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:39
dr. andreadis discusses toxicities with car t-cell therapy
-
0:55
dr. andreadis on response to car t-cell therapy
-
1:41
dr. andreadis on the current state of car t-cell therapy in lymphoma
-
1:01
dr. andreadis discusses the role of ibrutinib in dlbcl
-
1:19
dr. andreadis on developments to car t-cell therapy
-
1:11
dr. andreadis on car t-cell therapy in relapsed/refractory mcl
-
0:43
dr. andreadis on car t-cell therapy for pediatric all
-
3:01
candidates for car t-cell therapy in dlbcl
-
0:18
copy of dr. andreadis on response to car t-cell therapy
-
0:57
dr. andreadis on the treatment of relapsed dlbcl
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
0:53
dr. andreadis on treatment approaches in relapsed mcl
-
1:56
dr. perales on car t-cell therapy in dlbcl and follicular lymphoma
-
1:29
dr. perales on the future of car t-cell therapy in dlbcl and follicular lymphoma
-
0:53
expert discusses challenges of using car t-cell therapy to treat diffuse large b-cell lymphoma
-
0:48
dr. karmali on the future of car t-cell therapy in dlbcl
-
1:55
initial steps for treatment of dlbcl
-
1:05
updates on tafasitamab for the treatment of dlbcl
-
9:21
fda approval for axi-cel in nhl